Analysis of T-cell and Humoral Immune Response to SARS-CoV-2 Antigens in Rituximab-Treated Patients with Rheumatoid Arthritis Vaccinated with Combined Vector Vaccine Gam-COVID-Vac-Reference-Cited by-同舟云学术

Analysis of T-cell and Humoral Immune Response to SARS-CoV-2 Antigens in Rituximab-Treated Patients with Rheumatoid Arthritis Vaccinated with Combined Vector Vaccine Gam-COVID-Vac

Published:2024-04 Issue:6 Volume:176 Page:786-790
ISSN:0007-4888
Container-title:Bulletin of Experimental Biology and Medicine
language:en
Short-container-title:Bull Exp Biol Med

Author:

Omelchenko V. O.,Kurochkina Yu. D.,Fedorova A. V.,Ovchinnikov V. S.,Koval V. V.,Bratko I. V.,Letyagina E. A.,Korolev M. A.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10517-024-06109-9.pdf

Reference11 articles.

1. Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int. J. Mol. Sci. 2022;23(2):905. doi: https://doi.org/10.3390/ijms23020905

2. Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat. Rev. Rheumatol. 2021;17(2):71-72. doi: https://doi.org/10.1038/s41584-020-00562-2

3. D’Silva KM, Wallace ZS. COVID-19 and disease-modifying anti-rheumatic drugs. Curr. Rheumatol. Rep. 2021(23):5:28. https://doi.org/10.1007/s11926-021-00998-9

4. Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun. Rev. 2020;19(5):102523. doi: https://doi.org/10.1016/j.autrev.2020.102523

5. Korolev MA, Letyagina EA, Sizikov AE, Bogoderova LA, Ubshaeva YB, Omelchenko VO, Akimova AA, Mullagaliev AA, Chumasova OA, Kurochkina YD. Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugs. Ter. Arkh. 2022;94(5):636-641. doi: https://doi.org/10.26442/00403660.2022.05.201502